• Fund Type: FCP
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

UBS Lux Equity Fund - Biotech USD

+ Add to Watchlist

UBFC:GR

368.7200 EUR 2.1200 0.57%

As of 10:15:30 ET on 08/20/2014.

Snapshot for UBS Lux Equity Fund - Biotech USD (UBFC)

Open: 372.2100 High - Low: 373.0070 - 367.2800 Primary Exchange: Berlin
Volume: 15 52-Week Range: 258.4320 - 373.0070 Beta vs NSESWRLD: 1.1029

ETF Chart for UBFC

No chart data available.
  • UBFC:GR 373.0070
  • 1D
  • 1M
  • 1Y
370.8400
Interactive UBFC Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for UBFC

UBS Lux Equity Fund - Biotech USD is an open-end investment fund incorporated in Luxembourg. The Fund's objective is medium- to long-term capital growth. The Fund invests globally in equities of companies engaged in research, product development, product manufacturing and distribution in the biotechnology sector.

Inception Date: Telephone: 352-44-10-10-1 Tel
Managers: ANGUS W H MUIRHEAD
Web Site: www.ubs.com

Fundamentals for UBFC

NAV (on 2010-07-14) 162.7800
Assets (M) (on 2014-08-19) 1,119.5170
Shares out (M) 0.00
Market Cap (M) 0.00
% Premium -
Average 52-Week % Premium -
Fund Leveraged N

Dividends for UBFC

No dividends reported

Performance for UBFC

1-Month +20.03% 1-Year +42.70%
3-Month +27.41% 3-Year +46.55%
Year To Date +29.14% 5-Year +27.28%
Expense Ratio -

Top Fund Holdings for UBFC

Filing Date: 05/30/2014
Name Position Value % of Total
Biogen Idec Inc 305,700 97,631,409 10.076%
Gilead Sciences Inc 1,108,500 90,021,285 9.291%
Amgen Inc 750,114 87,005,723 8.979%
Celgene Corp 975,520 74,641,913 7.703%
Medivation Inc 660,000 48,067,800 4.961%
Alexion Pharmaceuticals Inc 281,300 46,785,816 4.829%
Regeneron Pharmaceuticals Inc 150,200 46,105,392 4.758%
BioMarin Pharmaceutical Inc 781,100 45,272,556 4.672%
Vertex Pharmaceuticals Inc 606,100 43,796,786 4.520%
Incyte Corp 811,000 40,185,050 4.147%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil